Health Care
Immune Design stock more than triples as it gets acquired by Merck
Merck (MRK) announced today that it will acquire immunotherapy developer Immune Design (IMDZ) for $5.85 per share in cash for an…
Agilent Technologies stock drops despite beating Q1 estimates
Agilent Technologies (A) stock dropped about 4% in the extended trading hours despite reporting upbeat Q1 results. The muted guidance…
Tilray resumes deal spree, signs fifth in 2 months
Tilray Inc. (TLRY) has taken the fusion spree seriously as a new deal has been signed to buy hemp food…
Aurora Cannabis shuffles its board of directors
Aurora Cannabis (ACB) on Wednesday announced the shuffle to its board of directors for aligning the directors' experience and expertise…
CVS Health reports mixed Q4 results; stock falls over 7%
CVS Health Corporation (CVS) reported better-than-expected earnings for the fourth quarter of 2018 but revenue fell short of estimates, sending…
Intercept stock surges on positive data from liver fibrosis drug study
Intercept Pharmaceuticals (ICPT) had surged about 25% in the pre-market session on Tuesday after the biopharma company announced positive topline…
CVS Health Q4 earnings preview: What to expect
CVS Health Corporation (CVS) is scheduled to report fourth-quarter earnings results before the regular trading hours on Wednesday, February 20.…